Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-23
1995-07-18
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514171, 514264, 514297, 546105, 546200, 546201, A61K 31445
Patent
active
054341701
ABSTRACT:
A method for treating a central nervous system or peripheral nervous system cholinergic deficit state in a mammalian organism in need of such treatment, said method comprising administering to said mammal an amount of thalidomide effective in the treatment of a cholinergic deficit state and for a time sufficient to achieve a suitable blood level to treat said cholinergic deficit state.
REFERENCES:
patent: 2830991 (1958-04-01), Keller et al.
patent: 4816456 (1989-03-01), Summers
patent: 4839364 (1989-06-01), Shutske et al.
patent: 5210087 (1993-05-01), Shutske et al.
patent: 5318967 (1994-06-01), Bruderer et al.
Andrulis Pharmaceuticals Corp.
Angres Isaac A.
Raymond Richard L.
LandOfFree
Method for treating neurocognitive disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating neurocognitive disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating neurocognitive disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2419116